Dechra Pharmaceuticals PLC Director/PDMR Shareholding (8577I)

TIDMDPH

RNS Number : 8577I

Dechra Pharmaceuticals PLC

22 June 2017

22 June 2017

Dechra Pharmaceuticals PLC

Notification of Transactions by Persons Discharging Managerial Responsibilities

Dechra Pharmaceuticals PLC has been notified that on 21 June 2017 Ian Page, Director, sold 134,500 ordinary shares in the Company at a price of GBP19.27 each.

Following this disposal Ian Page's beneficial interest in the Company is 676,808 shares (0.726% of the current issued share capital).

The Notification of Dealing Forms set out below are provided in accordance with Article 19.3 of MAR.

Notification of Dealing Form

 
 1.   Details of the Person Discharging Managerial Responsibility 
       ("PDMR")/person closely associated with them ("PCA") 
---  ------------------------------------------------------------------------ 
 a)   Name                                  Ian Page 
---  ------------------------------------  ---------------------------------- 
 2.   Reason for the notification 
---  ------------------------------------------------------------------------ 
 a)   Position/status                       Director 
---  ------------------------------------  ---------------------------------- 
 b)   Initial notification/                 Initial Notification 
       amendment 
---  ------------------------------------  ---------------------------------- 
 3.   Details of the Issuer 
---  ------------------------------------------------------------------------ 
 a)   Name                                  Dechra Pharmaceuticals PLC 
---  ------------------------------------  ---------------------------------- 
 b)   LEI code                              213800J4UVB5OWG8VX82 
---  ------------------------------------  ---------------------------------- 
 4.   Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of 
       transaction; (iii) each date; and (iv) each place 
       where transactions have been conducted 
---  ------------------------------------------------------------------------ 
 a)   Description                           Ordinary Shares of 1 pence each 
       of the financial 
       instrument 
                                             ISIN: GB0009633180 
       Identification 
       code 
---  ------------------------------------  ---------------------------------- 
 b)   Nature of the                         Sale of Shares 
       transaction 
---  ------------------------------------  ---------------------------------- 
 c)   Price(s) and                          Price(s)          Volume(s) 
       volumes(s) 
                                             GBP19.27          134,500 
---  ------------------------------------  ----------------  ---------------- 
 d)        Aggregated information           15,000 at 1942p 
             *    Aggregate volume           7,500 at 1934.49p 
                                             13,000 at 1935p 
                                             7,500 at 1935.42p 
             *    Price                      7,000 at 1931.32p 
                                             3,500 at 1930.6p 
                                             27,500 at 1927.5p 
             *    Total                      14,000 at 1925p 
                                             5,000 at 1925p 
                                             12,500 at 1926.42p 
                                             20,000 at 1910p 
                                             2,000 at 1910.41p 
                                             Total 
                                             134,500 
                                             1927.64p 
---  ------------------------------------  ---------------------------------- 
 e)   Date of the                           21 June 2017 
       transaction 
---  ------------------------------------  ---------------------------------- 
 f)   Place of the                          London Stock Exchange 
       transaction 
---  ------------------------------------  ---------------------------------- 
 

For further information, please contact:

Telephone number: 01606 814730

About Dechra

Dechra is an international specialist veterinary pharmaceuticals and related products business. Our expertise is in the development, manufacture, and sales and marketing of high quality products exclusively for veterinarians worldwide. Dechra's business is unique as the majority of its products are used to treat medical conditions for which there is no other effective solution or have a clinical or dosing advantage over competitor products. For more information please visit: www.dechra.com

Trademarks

Dechra and the Dechra "D" logo are registered trademarks of Dechra Pharmaceuticals PLC.

This information is provided by RNS

The company news service from the London Stock Exchange

END

DSHOKBDNOBKKPAB

(END) Dow Jones Newswires

June 22, 2017 03:36 ET (07:36 GMT)